We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
Cap. Flow
+$639M
Cap. Flow %
7.2%
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$37.2M
2
LIN icon
Linde
LIN
+$31.4M
3
TTWO icon
Take-Two Interactive
TTWO
+$30M
4
FISV
Fiserv Inc
FISV
+$27.4M
5
WMT icon
Walmart Inc
WMT
+$25.5M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$46.1M
2
PYPL icon
PayPal
PYPL
+$31.4M
3
AAPL icon
Apple
AAPL
+$31.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$28M
5
MRK icon
Merck
MRK
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Consumer Discretionary 15.85%
3 Healthcare 13.89%
4 Industrials 12.4%
5 Financials 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
2751
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$75K ﹤0.01%
27,452
-80,798
-75% -$201K
CTSO icon
2752
Cytosorbents Corp
CTSO
$22.6M
$73K ﹤0.01%
9,682
-3,019
-24% -$25.4K
DAKT icon
2753
Daktronics
DAKT
$1.04B
$73K ﹤0.01%
11,043
-36,249
-77% -$237K
ARQT icon
2754
Arcutis Biotherapeutics
ARQT
$3.18B
$72K ﹤0.01%
2,622
-11,147
-81% -$314K
SVRA icon
2755
Savara
SVRA
$1.19B
$72K ﹤0.01%
42,312
-94,961
-69% -$171K
PHAS
2756
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$71K ﹤0.01%
+19,132
New +$63.7K
BDSI
2757
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$70K ﹤0.01%
19,550
-41,350
-68% -$146K
EM
2758
DELISTED
Smart Share Global Ltd
EM
$69K ﹤0.01%
+11,300
New +$80.1K
LNTH icon
2759
Lantheus
LNTH
$6.59B
$69K ﹤0.01%
+2,505
New +$57.5K
CRBP icon
2760
Corbus Pharmaceuticals
CRBP
$190M
$68K ﹤0.01%
1,230
-2,089
-63% -$116K
CYCN icon
2761
Cyclerion Therapeutics
CYCN
$16.7M
$67K ﹤0.01%
+854
New +$53.5K
UGP icon
2762
Ultrapar
UGP
$6.54B
$67K ﹤0.01%
+17,866
New +$69.2K
WRN
2763
Western Copper and Gold
WRN
$544M
$67K ﹤0.01%
+33,598
New +$61.6K
AEIS icon
2764
Advanced Energy
AEIS
$13B
$66K ﹤0.01%
586
-1,588
-73% -$168K
PANL icon
2765
Pangaea Logistics
PANL
$485M
$63K ﹤0.01%
+12,629
New +$48.9K
OGI
2766
Organigram Holdings
OGI
$139M
$62K ﹤0.01%
+5,375
New +$61.2K
BLU
2767
DELISTED
BELLUS Health Inc.
BLU
$62K ﹤0.01%
20,058
– –
AMPE
2768
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$62K ﹤0.01%
124
-496
-80% -$266K
SQM icon
2769
Sociedad Química y Minera de Chile
SQM
$20.6B
$61K ﹤0.01%
1,283
-33,450
-96% -$1.65M
SMTS
2770
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$61K ﹤0.01%
+20,331
New +$67.3K
CTMX icon
2771
CytomX Therapeutics
CTMX
$754M
$60K ﹤0.01%
9,506
– –
OLMA icon
2772
Olema Pharmaceuticals
OLMA
$1.05B
$60K ﹤0.01%
+2,150
New +$61.2K
MBII
2773
DELISTED
Marrone Bio Innovations, Inc.
MBII
$60K ﹤0.01%
36,098
-19,011
-34% -$31.8K
CSLT
2774
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$59K ﹤0.01%
22,466
-48,278
-68% -$89.9K
EVGN icon
2775
Evogene
EVGN
$7.26M
$57K ﹤0.01%
1,663
-1,195
-42% -$46.8K
109 110
111
112 113

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
  • Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
  • Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
  • Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
  • Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
  • Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.